Our current study suggests that the transcriptional regulation of elastin-degrading enzymes may not be markedly affected by modest increases in the BMI and may only become evident at more advanced stages of obesity. The gene discussed is ELN; the disease is obesity due to melanocortin 4 receptor deficiency.